Intra-articular sodium hyaluronate reduces pain and improves function in osteoarthritis of knee

Clinical and Experimental Rheumatology

Volumn 19, Issue 1, 2001, Pages 9-10

  Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; HYALURONIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ARTHRALGIA; CARTILAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPOLYMERIZATION; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INJURY; KNEE FUNCTION; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYNOVIAL FLUID;

HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE; OSTEOARTHRITIS; PAIN;

EID: 0035093895     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomised clinical trial
2. Hyaluronic acid in the treatment of osteoarthritis of the knee
3. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update